Immune checkpoint inhibitor therapy is associated with a decreased risk of developing melanoma brain metastases

Abstract Background Despite recent advancements in metastatic melanoma treatment, the emergence of melanoma brain metastases (MBM) continues to pose a challenge. This study aimed to explore factors associated with MBM development. Methods This retrospective study included patients diagnosed with adv...

Full description

Saved in:
Bibliographic Details
Main Authors: Anna Fager, Matilda Samuelsson, Roger Olofsson Bagge, Aldina Pivodic, Sara Bjursten, Max Levin, Henrik Jespersen, Lars Ny
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:BJC Reports
Online Access:https://doi.org/10.1038/s44276-025-00137-2
Tags: Add Tag
No Tags, Be the first to tag this record!